Hemophagocytic syndrome: Laboratory and molecular characterization

BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome of fever, cytopenia, and organomegaly resulting from immune activation and cytokine storm. The syndrome can occur as a primary/familial form mostly affecting infants and young children or as an acquired form secondar...

Full description

Saved in:
Bibliographic Details
Main Authors: Nooran Salem Yaseen, Sadiq Khalaf Ali, Hussam Saadi Aziz
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-12-01
Series:Iraqi Journal of Hematology
Subjects:
Online Access:https://journals.lww.com/10.4103/ijh.ijh_36_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841551966356897792
author Nooran Salem Yaseen
Sadiq Khalaf Ali
Hussam Saadi Aziz
author_facet Nooran Salem Yaseen
Sadiq Khalaf Ali
Hussam Saadi Aziz
author_sort Nooran Salem Yaseen
collection DOAJ
description BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome of fever, cytopenia, and organomegaly resulting from immune activation and cytokine storm. The syndrome can occur as a primary/familial form mostly affecting infants and young children or as an acquired form secondary to an underlying pathology (infection, malignancy, and autoimmune disease) that may have an underlying genetic predisposition, including mutations or polymorphisms. PATIENTS AND METHODS: This case–control study was conducted in Basra, Iraq. Thirty-four pediatric and adult patients with peripheral cytopenia attributed to bone marrow (BM) hemophagocytosis enrolled with 34 healthy individuals (age and sex matched) included as a control group. Whole blood was tested for complete blood count and screened for the presence of mutations in the perforin gene by polymerase chain reaction amplification; in addition, serum samples were tested for soluble CD25, ferritin, and triglycerides (TGs). RESULTS: The mean hemoglobin level and platelets count were significantly lower in HLH patients compared to the control group (P < 0.001), while there was no significant statistical difference regarding neutrophils count (P > 0.05). Soluble CD25 (s.IL-2R) testing revealed inconsistent results; serum ferritin and TGs were significantly higher in HLH patients compared to the control group (P < 0.001). About nine cases were genetically proven to have primary HLH; all were infants under the age of 6 months. Perforin gene mutations were detected in 38.8% (n = 7) of tested subjects. The novel frameshift mutation of the perforin gene (c.218_224del) was identified in four cases. Fifteen different perforin gene polymorphisms were detected in both case and control groups. Six out of nine infants with primary HLH did not survive, while the remaining three cases underwent BM transplantation. CONCLUSION: Early diagnosis of HLH is often challenging; this study should increase awareness of the prevalence of familial HLH among infants; such cases require early recognition and referral to hematopoietic stem cell transplantation.
format Article
id doaj-art-24706083cf004edbb87639089eb00326
institution Kabale University
issn 2072-8069
2543-2702
language English
publishDate 2024-12-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Iraqi Journal of Hematology
spelling doaj-art-24706083cf004edbb87639089eb003262025-01-09T13:53:07ZengWolters Kluwer Medknow PublicationsIraqi Journal of Hematology2072-80692543-27022024-12-0113219520110.4103/ijh.ijh_36_24Hemophagocytic syndrome: Laboratory and molecular characterizationNooran Salem YaseenSadiq Khalaf AliHussam Saadi AzizBACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome of fever, cytopenia, and organomegaly resulting from immune activation and cytokine storm. The syndrome can occur as a primary/familial form mostly affecting infants and young children or as an acquired form secondary to an underlying pathology (infection, malignancy, and autoimmune disease) that may have an underlying genetic predisposition, including mutations or polymorphisms. PATIENTS AND METHODS: This case–control study was conducted in Basra, Iraq. Thirty-four pediatric and adult patients with peripheral cytopenia attributed to bone marrow (BM) hemophagocytosis enrolled with 34 healthy individuals (age and sex matched) included as a control group. Whole blood was tested for complete blood count and screened for the presence of mutations in the perforin gene by polymerase chain reaction amplification; in addition, serum samples were tested for soluble CD25, ferritin, and triglycerides (TGs). RESULTS: The mean hemoglobin level and platelets count were significantly lower in HLH patients compared to the control group (P < 0.001), while there was no significant statistical difference regarding neutrophils count (P > 0.05). Soluble CD25 (s.IL-2R) testing revealed inconsistent results; serum ferritin and TGs were significantly higher in HLH patients compared to the control group (P < 0.001). About nine cases were genetically proven to have primary HLH; all were infants under the age of 6 months. Perforin gene mutations were detected in 38.8% (n = 7) of tested subjects. The novel frameshift mutation of the perforin gene (c.218_224del) was identified in four cases. Fifteen different perforin gene polymorphisms were detected in both case and control groups. Six out of nine infants with primary HLH did not survive, while the remaining three cases underwent BM transplantation. CONCLUSION: Early diagnosis of HLH is often challenging; this study should increase awareness of the prevalence of familial HLH among infants; such cases require early recognition and referral to hematopoietic stem cell transplantation.https://journals.lww.com/10.4103/ijh.ijh_36_24basrafamilial hemophagocytic lymphohistiocytosisiraqprf1
spellingShingle Nooran Salem Yaseen
Sadiq Khalaf Ali
Hussam Saadi Aziz
Hemophagocytic syndrome: Laboratory and molecular characterization
Iraqi Journal of Hematology
basra
familial hemophagocytic lymphohistiocytosis
iraq
prf1
title Hemophagocytic syndrome: Laboratory and molecular characterization
title_full Hemophagocytic syndrome: Laboratory and molecular characterization
title_fullStr Hemophagocytic syndrome: Laboratory and molecular characterization
title_full_unstemmed Hemophagocytic syndrome: Laboratory and molecular characterization
title_short Hemophagocytic syndrome: Laboratory and molecular characterization
title_sort hemophagocytic syndrome laboratory and molecular characterization
topic basra
familial hemophagocytic lymphohistiocytosis
iraq
prf1
url https://journals.lww.com/10.4103/ijh.ijh_36_24
work_keys_str_mv AT nooransalemyaseen hemophagocyticsyndromelaboratoryandmolecularcharacterization
AT sadiqkhalafali hemophagocyticsyndromelaboratoryandmolecularcharacterization
AT hussamsaadiaziz hemophagocyticsyndromelaboratoryandmolecularcharacterization